Gene Symbol | CCL8 |
Entrez ID | 6355 |
Uniprot ID | P80075 |
Description | chemokine (C-C motif) ligand 8 |
Chromosomal Location | chr17: 34,319,036-34,321,402 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0002548 |
monocyte chemotaxis |
The movement of a monocyte in response to an external stimulus. |
IBA |
BP |
GO:0002687 |
positive regulation of leukocyte migration |
Any process that activates or increases the frequency, rate, or extent of leukocyte migration. |
IEA |
BP |
GO:0006468 |
protein phosphorylation |
The process of introducing a phosphate group on to a protein. |
IEA |
BP |
GO:0006816 |
calcium ion transport |
The directed movement of calcium (Ca) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IDA |
BP |
GO:0006874 |
cellular calcium ion homeostasis |
Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell. |
IDA |
BP |
GO:0006887 |
exocytosis |
A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle by fusion of the vesicle with the plasma membrane of a cell. This process begins with steps that prepare vesicles for fusion with the membrane (tethering and docking) and ends when vesicle fusion is complete. This is the process in which most molecules are secreted from eukaryotic cells. |
IDA |
BP |
GO:0006935 |
chemotaxis |
The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
TAS |
BP |
GO:0006954 |
inflammatory response |
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
IBA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007186 |
G-protein coupled receptor signaling pathway |
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
IBA |
BP |
GO:0007267 |
cell-cell signaling |
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
IDA |
BP |
GO:0009615 |
response to virus |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. |
TAS |
BP |
GO:0030593 |
neutrophil chemotaxis |
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
IBA |
BP |
GO:0043547 |
positive regulation of GTPase activity |
Any process that activates or increases the activity of a GTPase. |
IBA |
BP |
GO:0048247 |
lymphocyte chemotaxis |
The directed movement of a lymphocyte in response to an external stimulus. |
IBA |
BP |
GO:0050729 |
positive regulation of inflammatory response |
Any process that activates or increases the frequency, rate or extent of the inflammatory response. |
IBA |
BP |
GO:0070098 |
chemokine-mediated signaling pathway |
A series of molecular signals initiated by the binding of a chemokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IBA |
BP |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
IBA |
BP |
GO:0070664 |
negative regulation of leukocyte proliferation |
Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte proliferation. |
IEA |
BP |
GO:0071346 |
cellular response to interferon-gamma |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far. |
IBA |
BP |
GO:0071347 |
cellular response to interleukin-1 |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
IBA |
BP |
GO:0071356 |
cellular response to tumor necrosis factor |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
IBA |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IBA |
CC |
GO:0005623 |
cell |
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope. |
IEA |
MF |
GO:0004672 |
protein kinase activity |
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
IDA |
MF |
GO:0008009 |
chemokine activity |
The function of a family of small chemotactic cytokines; their name is derived from their ability to induce directed chemotaxis in nearby responsive cells. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria. |
IEA |
MF |
GO:0008201 |
heparin binding |
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. |
IEA |
MF |
GO:0016004 |
phospholipase activator activity |
Increases the activity of a phospholipase, an enzyme that catalyzes of the hydrolysis of a glycerophospholipid. |
IDA |
MF |
GO:0048020 |
CCR chemokine receptor binding |
Interacting selectively and non-covalently with a CCR chemokine receptor. |
IBA |
Domain ID | Description |
---|---|
IPR000827 |
CC chemokine, conserved site |
IPR001811 |
Chemokine interleukin-8-like domain |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04060 |
Cytokine-cytokine receptor interaction |
KEGG |
hsa04062 |
Chemokine signaling pathway |
KEGG |
UMLS CUI | UMLS Term |
---|---|
C0003873 |
Rheumatoid Arthritis |
C0020517 |
Hypersensitivity |
C0021400 |
Influenza |
C0032285 |
Pneumonia |
C0035228 |
Respiratory Hypersensitivity |
C1619692 |
Nephrogenic Fibrosing Dermopathy |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22344199 |
Chazenbalk et al. |
2012 |
Abnormal Expression of Genes Involved in Inflammation, Lipid Metabolism, and Wnt Signaling in the Adipose Tissue of Polycystic Ovary Syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
CCR4 |
1233 |
P51679 |
0.00 |
CX3CR1 |
1524 |
P49238 |
0.00 |
CCR10 |
2826 |
P46092 |
0.00 |
CXCL10 |
3627 |
P02778 |
0.00 |
CXCR4 |
7852 |
P61073 |
0.00 |
CXCR6 |
10663 |
O00574 |
0.00 |
CCR9 |
10803 |
P51686 |
0.00 |
CCR1 |
1230 |
P32246 |
0.52 |
CCR3 |
1232 |
P51677 |
0.55 |
CCR5 |
1234 |
P51681 |
0.62 |
CCR2 |
729230 |
P41597 |
0.63 |
VCAN |
1462 |
P13611 |
0.75 |
ACKR1 |
2532 |
Q16570 |
0.52 |
MMP3 |
4314 |
P08254 |
0.52 |
ACKR4 |
51554 |
Q9NPB9 |
0.52 |
ACKR2 |
1238 |
O00590 |
0.75 |